Persistent infection with oncogenic human papillomavirus (HPV) is necessary but not
sufficient for the development of cervical cancer. The factors promoting persistence as well …

High prevalence and mortality rates of cervical cancer create an imperative need to clarify
the uniqueness of HPV (Human Papillomavirus) infection, which serves as the key causative …

Background In addition to HPV, high parity and hormonal contraceptives have been
associated with cervical cancer (CC). However, most of the evidence comes from …

Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The
availability of prophylactic vaccines for high-risk types of human papillomavirus (HPV) …

A murine papillomavirus, MmuPV1, infects both cutaneous and mucosal epithelia of
laboratory mice and can be used to model high-risk human papillomavirus (HPV) infection …

Globally, human papilloma virus (HPV) infection is a common sexually transmitted disease.
However, most of the HPV infections eventually resolve aided by the body's efficient cell …

Human papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors
like regional variability, HPV genotype, the population studied, HPV vaccination status, and …

Objective Studies on the effect of long-term use of combined oral contraceptives (COCs) on
cervical dysplasia and/or cancer risk have been inconsistent. Less is known about the …

Introduction Persistent human papillomavirus infection is an important factor in the
development of cervical cancer, which is usually a long process evolving from the …

Cervical cancer occurs most often in under-screened women. In this nationwide register
study, we described differences in sociodemographic characteristics between passive and …